Regulatory Alerts

Keep up-to-date with key announcements and guidance from organisations including NICE, DHSC and MHRA.

SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery

Prescribers should consider this risk in the context of an individual patient’s bleeding and thrombotic risk assessment during the peripartum period and the benefits of antidepressants for the patient’s mental health during this time.
Go to the profile of OnMedica
Jan 07, 2021